CA45562-5A - 0x0000000000006615

Males & Females of Non-Childbearing Potential

Mountain

* Stipend may pay up to reflected amount.
Start Date: 
March 25, 2025 - 3:15pm
End Date: 
April 12, 2025 - 12:45pm

Study Details

Study Number: CA45562
Group Number: 5A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease.
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type: Short Term
Study Length: 6 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Wednesday 3/19/2025
Thursday 3/20/2025
Monday 3/24/2025

Doctor Exam Dates:

Event Day Event Date
Wednesday 3/19/2025
Thursday 3/20/2025
Monday 3/24/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 3/25/2025 3:15:00 PM 3/31/2025 9:45:00 AM 1 Lincoln
Phone participant Saturday 4/12/2025 12:45:00 PM 2 Lincoln